← All companies
PIII
P3 Health Partners Inc.
$0.02
+0.00 +21.95%
Key statistics
from XBRL data in SEC filingsMarket cap
$126K
Revenue (TTM)
$1.47B
Net income (TTM)
-$126M
EPS (TTM)
$-38.66
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$25.5M
Total assets
$674M
Gross margin
—
52-week range
$0.01 – $0.02
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Entered a material agreement
Jul 6, 2026
8-K
Shareholder vote results
Jun 10, 2026
8-K
Delisting notice or listing-rule failure
May 26, 2026
8-K
Delisting notice or listing-rule failure; Other events
May 15, 2026
10-Q
Quarter ended 2026-03-31
May 14, 2026
8-K
Results of operations (earnings release)
May 14, 2026
8-K
Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws
Apr 28, 2026
10-K
Fiscal year ended 2025-12-31
Mar 26, 2026
8-K
Results of operations (earnings release)
Mar 26, 2026
8-K
Entered a material agreement
Mar 25, 2026
8-K
Entered a material agreement
Feb 17, 2026
8-K
Delisting notice or listing-rule failure
Nov 28, 2025
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K
Results of operations (earnings release)
Nov 14, 2025
8-K
Entered a material agreement
Nov 14, 2025
8-K
Entered a material agreement
Aug 29, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Results of operations (earnings release)
Aug 14, 2025
8-K
Director or officer change
Jul 9, 2025
8-K
Shareholder vote results
Jun 10, 2025
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Jun 3, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
8-K
Results of operations (earnings release)
May 15, 2025
8-K
Modified rights of security holders; Amended charter or bylaws
Apr 17, 2025
8-K
Other events
Apr 4, 2025
8-K
Shareholder vote results
Apr 3, 2025
10-K
Fiscal year ended 2024-12-31
Mar 28, 2025
8-K
Results of operations (earnings release)
Mar 27, 2025
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Feb 18, 2025
8-K
Regulation FD disclosure
Feb 13, 2025
8-K
Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Dec 17, 2024
10-Q
Quarter ended 2024-09-30
Nov 12, 2024
8-K
Results of operations (earnings release)
Nov 12, 2024
8-K
Director or officer change
Aug 29, 2024
10-Q
Quarter ended 2024-06-30
Aug 7, 2024
8-K
Results of operations (earnings release)
Aug 7, 2024
8-K
Shareholder vote results
Jun 7, 2024
8-K
Entered a material agreement; Unregistered sale of equity
May 24, 2024
8-K
Entered a material agreement; Unregistered sale of equity
May 23, 2024
8-K
Delisting notice or listing-rule failure
May 20, 2024